Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 02, 2015 4:19 AM ET


Company Overview of Eleven Biotherapeutics, Inc.

Key Executives for Eleven Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
Abbie C. Celniker Ph.D.43 RelationshipsChief Executive Officer, President and Director56
Reza Dana M.D., MPH,M.ScNo RelationshipsFounder--
K. Christopher Garcia Ph.D.No RelationshipsCo-Founder--
Gregory L. Verdine Ph.D.33 RelationshipsCo-Founder56
Casey T. Weaver M.D.No RelationshipsCo-Founder--
View More Key Executives

Eleven Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel S. Lynch M.B.A 88 RelationshipsBlueprint Medicines Corporation57
Abbie C. Celniker Ph.D. 43 RelationshipsEleven Biotherapeutics, Inc.56
Jane Pritchett V. Henderson 8 RelationshipsKolltan Pharmaceuticals, Inc.49
David A. Berry M.D., Ph.D. 48 RelationshipsPronutria Biosciences, Inc.37
Cary G. Pfeffer M.D. 25 RelationshipsThird Rock Ventures, LLC53
View All Board Members

Eleven Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jane Pritchett V. Henderson8 Relationships3 Executives
Compensation Committee M.B.ADaniel S. Lynch88 Relationships3 Executives
Nominating Committee M.B.ADaniel S. Lynch88 Relationships3 Executives
Corporate Governance Committee M.B.ADaniel S. Lynch88 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$570.9K
Compensation as of Fiscal Year 2014
Eleven Biotherapeutics, Inc. CEO Compensation
Industry Average


Vinda International Holdings Limited Announces Board Changes
June 30, 2015 8:30 AM ET
Pee Cee Cosma Sope Ltd Announces Executive Changes
June 23, 2015 9:49 AM ET
Kimberly-Clark Elects Michael D. White to its Board of Directors
June 22, 2015 1:00 PM ET
Hipolin Announces Resignation of Nilesh Rajnikant Desai as Independent Director
June 10, 2015 10:30 AM ET
Frank A. Tataseo, Executive Vice President - New Business Development to Retire from the Clorox Company, Effective October 1, 2015
June 03, 2015 9:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eleven Biotherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at